XERS

NASDAQ · Equity

Xeris Pharmaceuticals Inc

US Healthcare Drug Manufacturers - Specialty & Generic

Latest week
29 May 2026
Close
6.160000
Fair value
4.119231
Expectation
Undecided 49.47%
Weekly Close Trend Line Fair Value Activity Lines

Chart Summary

Key Points

Week Ending
29 May 2026
Latest Close
6.16
12-Week Change
12.82%
Trend Signal
Inactive
Expectation
Undecided 49.47%
Signal Weeks
0 of 12
Vs Trend Line
Below
Vs Fair Value
Above
Relative Strength
-24.83
Market Dynamics
0.28

Over the latest 12 completed weeks ending 2026-05-29, XERS rose 12.82%, moving from 5.46 to 6.16. The latest weekly close is below the Trend Line and above Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -24.83 and has softened across the 12-week window. Market Dynamics is 0.28 on the latest week. Expectation is undecided at 49.47%.